Email this article 
Effectiveness of pembrolizumab in therapy of sarcomatoid variant of metastatic urothelial carcinoma. Clinical case
- Authors: Polyakova A.S.1, Sokolov E.A.1,2, Pushkar D.Y.1,2,3
-
Affiliations:
- S.P. Botkin Moscow Multidisciplinary Scientific and Clinical Center, Moscow Healthcare Department
- Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia
- Russian University of Medicine, Ministry of Health of Russia
- Issue: Vol 20, No 4 (2024)
- Pages: 104-111
- Section: CLINICAL NOTES
- Published: 01.12.2024
- URL: https://oncourology.abvpress.ru/oncur/article/view/1857
- DOI: https://doi.org/10.17650/1726-9776-2024-20-4-104-111
- ID: 1857
Cite item
Full Text
Abstract
Sarcomatoid variant of urothelial carcinoma is a rare histological subtype: it is diagnosed in 0.1–0.3 % of all neoplasms of the bladder. The standard 1st line therapy for all types of advanced urothelial carcinoma is chemotherapy which does not necessarily allow to achieve the best or complete responses, especially in the presence of sarcomatoid differentiation. High programmed cell death-ligand 1 (PD-L1) expression in this morphological subtype allows to assume better results of immunotherapy compared to chemotherapy. However, a large number of observations is necessary to confirm this hypothesis and suggest pembrolizumab immunotherapy as a standard 1st line therapy for metastatic urothelial carcinoma with sarcomatoid differentiation.
About the authors
A. S. Polyakova
S.P. Botkin Moscow Multidisciplinary Scientific and Clinical Center, Moscow Healthcare Department
Author for correspondence.
Email: plkvs46@mail.ru
ORCID iD: 0000-0003-3468-8758
SPIN-code: 9695-5092
Aleksandra S. Polyakova.
5 2nd Botkinskiy Proezd, Moscow 125284
Russian FederationE. A. Sokolov
S.P. Botkin Moscow Multidisciplinary Scientific and Clinical Center, Moscow Healthcare Department; Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia
ORCID iD: 0000-0002-8887-5789
5 2nd Botkinskiy Proezd, Moscow 125284; Build. 1, 2/1 Barrikadnaya St., Moscow 125993
Russian FederationD. Yu. Pushkar
S.P. Botkin Moscow Multidisciplinary Scientific and Clinical Center, Moscow Healthcare Department; Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia; Russian University of Medicine, Ministry of Health of Russia
ORCID iD: 0000-0002-6096-5723
5 2nd Botkinskiy Proezd, Moscow 125284; Build. 1, 2/1 Barrikadnaya St., Moscow 125993; 4 Dolgorukovskaya St., Moscow 127006
Russian FederationReferences
Supplementary files
